barium has been researched along with Neuroendocrine Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakke, I; Espevik, T; Gustafsson, BI; Kidd, M; Modlin, IM; Pfragner, R; Rokstad, AM; Svejda, B | 1 |
| Mergler, S; Prada, J; Wiedenmann, B | 1 |
2 other study(ies) available for barium and Neuroendocrine Tumors
| Article | Year |
|---|---|
Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studies.
Topics: Adrenergic beta-Agonists; Alginates; Barium; Biocompatible Materials; Calcium; Capsules; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Glucuronic Acid; Hexuronic Acids; Humans; Intestine, Small; Isoproterenol; Microscopy, Confocal; Microspheres; Models, Biological; Neuroendocrine Tumors; Serotonin; Spheroids, Cellular; Time Factors | 2012 |
R-type Ca(2+)-channel activity is associated with chromogranin A secretion in human neuroendocrine tumor BON cells.
Topics: Barium; Calcium; Calcium Channel Blockers; Calcium Channels, R-Type; Calcium Signaling; Chromogranin A; Chromogranins; Humans; Intracellular Fluid; Ion Transport; Neoplasm Proteins; Neuroendocrine Tumors; Pancreatic Neoplasms; Patch-Clamp Techniques; Spider Venoms; Tumor Cells, Cultured | 2003 |